α2 Adrenoceptor: a Target for Neuropathic Pain Treatment (original) (raw)
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment
Letizia Crocetti
2017
View PDFchevron_right
Antinociception induced by a novel α2A adrenergic receptor agonist in rodents acute and chronic pain models
Guilherme Carneiro Montes
European Journal of Pharmacology, 2017
View PDFchevron_right
Chronic treatment with agonists of β2-adrenergic receptors in neuropathic pain
Luc-Henri Tessier
Experimental Neurology, 2010
View PDFchevron_right
Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action
Troels Jensen
Pain, 1999
View PDFchevron_right
The effects of dexmedetomidine alone and in combination with tramadol or amitriptyline in a neuropathic pain model
Marie Moftah
Pain physician
View PDFchevron_right
Pharmacotherapy of Neuropathic Pain
Chandrashekhar Upasani
Seminars in Neurology, 1994
View PDFchevron_right
Overview of the Pharmacological Management of Neuropathic Pain
Research in Pharmacy and Health Sciences
Research in Pharmacy and Health Sciences, 2016
View PDFchevron_right
Pharmacological management of neuropathic pain
M. León
Revista …, 2009
View PDFchevron_right
Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
Srinivasa Raja
Mayo Clinic Proceedings, 2010
View PDFchevron_right
Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
ROBERT SEGRAVES
Current …, 2009
View PDFchevron_right
Pharmacological Management of Neuropathic Pain: Current Trends and Possible Approaches
Sukant Garg
Archives of Neuroscience, 2016
View PDFchevron_right
Involvement of α2-adrenoceptors in inhibitory and facilitatory pain modulation processes
Lechi Vo
European Journal of Pain, 2015
View PDFchevron_right
Discovery of Selective Alpha 2C Adrenergic Receptor Agonists
eric jnoff
ChemMedChem, 2012
View PDFchevron_right
Neuropathic pain: new mechanisms of action of old drugs
Zbigniew Zylicz
Palliative Medicine in Practice
View PDFchevron_right
Differential and Synergistic Effects of Selective Norepinephrine and Serotonin Reuptake Inhibitors in Rodent Models of Pain
Kathryn Rogers
Journal of Pharmacology and Experimental Therapeutics, 2006
View PDFchevron_right
Recent advances in pharmacological treatment of neuropathic pain
Troels Jensen
F1000 Medicine Reports, 2010
View PDFchevron_right
Anti-allodynic Efficacy of NMDA Antagonist Peptide and Noradrenaline Alone and in Combination in Rodent Neuropathic Pain Model
Sajjad Salari
The Korean Journal of Pain, 2015
View PDFchevron_right
Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
Arunas Sciupokas, Jurga Bernatoniene
Pharmaceutics
View PDFchevron_right
Antidepressant treatment of neuropathic pain: looking for the mechanism
Luc-Henri Tessier
Future Neurology, 2010
View PDFchevron_right
Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain
Michael Ossipov
Neuroscience letters, 2014
View PDFchevron_right
The Contribution of Alpha-1 and Alpha-2 Adrenoceptors in Peripheral Imidazoline and Adrenoceptor Agonist-Induced Nociception
Tayfun Uzbay
Anesthesia & Analgesia, 2006
View PDFchevron_right
Analgesic Effects of Vilazodone, Indatraline, and Talsupram in a Rat Model of Neuropathic Pain
Levent HACISULEYMAN
Turkish Journal of Pharmaceutical Sciences, 2021
View PDFchevron_right
Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects
Jana Sawynok
Pain, 1999
View PDFchevron_right
Antiepileptic Drugs in the Treatment of Neuropathic Pain
Veronique Trombert
Drugs, 2007
View PDFchevron_right
Cardiovascular effects of chronic treatment with a β2-adrenoceptor agonist relieving neuropathic pain in mice
Laurent Monassier
Neuropharmacology, 2011
View PDFchevron_right
Subarachnoid Serotonergic and Noradrenergic Antagonists increase the Pain Response in Rats
Naira Pelógia
Brazilian Journal of Anesthesiology, 2011
View PDFchevron_right
Involvement of Opioid Receptors and α2-Adrenoceptors in Inhibitory Pain Modulation Processes: A Double-Blind Placebo-Controlled Crossover Study
Lechi Vo
The Journal of Pain, 2016
View PDFchevron_right
Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral δ-opioid receptors
Victor Hruby is to
Neuroscience Letters, 2007
View PDFchevron_right
Contribution of α 2 receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine
Linda Hedley
British Journal of Pharmacology, 2001
View PDFchevron_right
Is There a Place for β-Mimetics in Clinical Management of Neuropathic Pain? Salbutamol Therapy in Six Cases
Evren Eker
Anesthesiology, 2010
View PDFchevron_right
Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance
Andrea Hebb
BMJ, 2010
View PDFchevron_right
Antinociceptive effects of intrathecal administration of [alpha]-adrenoceptor antagonists and clonidine in the formalin test in the mouse
A. Tjølsen
Neuropharmacology, 1993
View PDFchevron_right
WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression
G. Whiteside
British Journal of Pharmacology, 2010
View PDFchevron_right
Antinociceptive effects of intrathecal administration of α-adrenoceptor antagonists and clonidine in the formalin test in the mouse
A. Tjølsen
Neuropharmacology, 1993
View PDFchevron_right